0.10 | 0.65%
| Price and Volume | |
|---|---|
| Recent Price | 15.42 |
| 52 Week High | 19.37 |
| 52 Week Low | 12.35 |
| Avg. Daily Vol. (Mil) | 0.17 |
| Beta (3 year) | 0.38 |
| Share Related Items | |
| Mkt Cap (Mil) | 510.19 |
| Shares Out (Mil) | 33.09 |
| Float (Mil) | 23.42 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.40 |
| Current Ratio | 4.40 |
| LT Debt/ Equity | 0.13 |
| Total Debt / Equity | 0.14 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 3.72 |
| Price/Book | 2.76 |
| Price/Cash Flow | 31.40 |
| Per Share Data | |
| Earnings | -0.11 |
| Sales | 4.14 |
| Book Value | 5.59 |
| Cash Flow | 0.49 |
| Business Summary | |
|---|---|
| Quidel Corporation is engaged in the development, manufacturing and marketing of rapid diagnostic solutions for decentralized applications including point-of-care in infectious diseases and reproductive and women's health. | |
| General Information | |
| 10165 McKellar Court
San Diego, CA 92121 |
|
| www.quidel.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 488 | |
| CEO: Douglas C. Bryant | |
| Short Interest | |
| Current Month (Mil) | 4.90 |
| Previous Month (Mil) | 4.87 |
| Short Interest Ratio (Days) | 23.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -1.60 |
| Return on Investments | -1.80 |
| Profitability | |
| Gross Margin | 67.40 |
| EBIT Margin | -2.90 |
| Profit Margin | -2.70 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,430.15 | 1,315.94 | 2,834.33 | 16.31 |
Oil *
103.41
|
|
DOWN
150.54 |
DOWN
16.48 |
DOWN
36.66 |
DOWN
1.00 |
10 Yr
1.63%
SPDR Gold
150.33
|
|
-1.20%
|
-1.24%
|
-1.28%
|
-5.78%
|
Data delayed 20 minutes |
Connect with TheStreet